Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Chiral mesoporous silica based LOFL delivery systems using achiral alcohols as co-structure-directing agents: Construction, characterization, sustained release and antibacterial activity.

Cui M, Xie L, Zhang S, Chen L, Xi Y, Wang Y, Guo Y, Xu L.

Colloids Surf B Biointerfaces. 2019 Sep 5;184:110483. doi: 10.1016/j.colsurfb.2019.110483. [Epub ahead of print]

PMID:
31522027
2.

Design and preparation of mesoporous silica carriers with chiral structures for drug release differentiation.

Wang Y, Li W, Liu T, Xu L, Guo Y, Ke J, Li S, Li H.

Mater Sci Eng C Mater Biol Appl. 2019 Oct;103:109737. doi: 10.1016/j.msec.2019.109737. Epub 2019 May 10.

PMID:
31349514
3.

A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.

Li-Hong W, Xin C, Hui X, Li-Li Z, Jing H, Mei-Juan Z, Jie L, Yi L, Jin-Wen L, Wei Z, Gang C.

Int J Pharm. 2013 Sep 15;454(1):135-42. doi: 10.1016/j.ijpharm.2013.07.027. Epub 2013 Jul 17.

PMID:
23871738
4.

Enantioselectively controlled release of chiral drug (metoprolol) using chiral mesoporous silica materials.

Guo Z, Du Y, Liu X, Ng SC, Chen Y, Yang Y.

Nanotechnology. 2010 Apr 23;21(16):165103. doi: 10.1088/0957-4484/21/16/165103. Epub 2010 Mar 30.

PMID:
20351409
5.

Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.

Geng H, Zhao Y, Liu J, Cui Y, Wang Y, Zhao Q, Wang S.

Int J Pharm. 2016 Aug 20;510(1):184-94. doi: 10.1016/j.ijpharm.2016.05.067. Epub 2016 Jun 2.

PMID:
27262268
6.

Biomimetic synthesized chiral mesoporous silica: Structures and controlled release functions as drug carrier.

Li J, Xu L, Yang B, Bao Z, Pan W, Li S.

Mater Sci Eng C Mater Biol Appl. 2015 Oct;55:367-72. doi: 10.1016/j.msec.2015.05.039. Epub 2015 May 9.

PMID:
26117767
7.

The On-Off chiral mesoporous silica nanoparticles for delivering achiral drug in chiral environment.

Fan N, Liu R, Ma P, Wang X, Li C, Li J.

Colloids Surf B Biointerfaces. 2019 Apr 1;176:122-129. doi: 10.1016/j.colsurfb.2018.12.065. Epub 2018 Dec 26.

PMID:
30597409
8.

Molecular imprinting functionalized silica xerogel for selective recognition of levorotatory ofloxacin.

Li J, Li S, He Z.

Mater Sci Eng C Mater Biol Appl. 2017 Feb 1;71:999-1003. doi: 10.1016/j.msec.2016.11.015. Epub 2016 Nov 8.

PMID:
27987799
9.

Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.

Zhu W, Wan L, Zhang C, Gao Y, Zheng X, Jiang T, Wang S.

Mater Sci Eng C Mater Biol Appl. 2014 Jan 1;34:78-85. doi: 10.1016/j.msec.2013.08.014. Epub 2013 Aug 17.

PMID:
24268236
10.

Mesoporous silicas templated by heterocyclic amino acid derivatives: Biomimetic synthesis and drug release application.

Li H, Ke J, Li H, Wei C, Wu X, Li J, Yang Y, Xu L, Liu H, Li S, Yang M, Wei M.

Mater Sci Eng C Mater Biol Appl. 2018 Dec 1;93:407-418. doi: 10.1016/j.msec.2018.07.081. Epub 2018 Aug 2.

PMID:
30274073
11.

Fabrication of mesoporous silica shells on solid silica spheres using anionic surfactants and their potential application in controlling drug release.

El-Toni AM, Khan A, Ibrahim MA, Al-Hoshan M, Labis JP.

Molecules. 2012 Nov 6;17(11):13199-210. doi: 10.3390/molecules171113199.

12.

Enlarged Pore Size Chiral Mesoporous Silica Nanoparticles Loaded Poorly Water-Soluble Drug Perform Superior Delivery Effect.

Guo Y, Gou K, Yang B, Wang Y, Pu X, Li S, Li H.

Molecules. 2019 Sep 30;24(19). pii: E3552. doi: 10.3390/molecules24193552.

13.

Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.

Abd-Elrahman AA, El Nabarawi MA, Hassan DH, Taha AA.

Drug Deliv. 2016 Nov;23(9):3387-3398. Epub 2016 Jun 3.

PMID:
27167529
14.

Formulation and In Vitro Characterization of Bioactive Mesoporous Silica with Doxorubicin and Metronidazole Intended for Bone Treatment and Regeneration.

Czarnobaj K, Prokopowicz M, Sawicki W.

AAPS PharmSciTech. 2017 Nov;18(8):3163-3171. doi: 10.1208/s12249-017-0804-3. Epub 2017 May 22.

PMID:
28534298
15.

Co-synthesis and drug delivery properties of mesoporous hydroxyapatite-silica composites.

Zhao YF, Loo SC, Ma J.

J Nanosci Nanotechnol. 2009 Jun;9(6):3720-7. Erratum in: J Nanosci Nanotechnol. 2010 Jan;10(1):following 649. Loo, S C J [added].

PMID:
19504909
16.

Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.

Li T, Geng T, Md A, Banerjee P, Wang B.

Colloids Surf B Biointerfaces. 2019 Apr 1;176:185-193. doi: 10.1016/j.colsurfb.2019.01.004. Epub 2019 Jan 2.

PMID:
30616109
17.

Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.

Ma'mani L, Nikzad S, Kheiri-Manjili H, Al-Musawi S, Saeedi M, Askarlou S, Foroumadi A, Shafiee A.

Eur J Med Chem. 2014 Aug 18;83:646-54. doi: 10.1016/j.ejmech.2014.06.069. Epub 2014 Jun 28.

PMID:
25014638
18.

Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel.

He Y, Liang S, Long M, Xu H.

Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:12-17. doi: 10.1016/j.msec.2017.04.049. Epub 2017 Apr 8.

PMID:
28575958
19.

Multilayer encapsulated mesoporous silica nanospheres as an oral sustained drug delivery system for the poorly water-soluble drug felodipine.

Hu L, Sun H, Zhao Q, Han N, Bai L, Wang Y, Jiang T, Wang S.

Mater Sci Eng C Mater Biol Appl. 2015 Feb;47:313-24. doi: 10.1016/j.msec.2014.10.067. Epub 2014 Oct 24.

PMID:
25492202
20.

Magnetic Fe3O4@mesoporous silica composites for drug delivery and bioadsorption.

Huang S, Li C, Cheng Z, Fan Y, Yang P, Zhang C, Yang K, Lin J.

J Colloid Interface Sci. 2012 Jun 15;376(1):312-21. doi: 10.1016/j.jcis.2012.02.031. Epub 2012 Feb 28.

PMID:
22444483

Supplemental Content

Support Center